People
Centers & Teams
Centers & Teams
Find information about our Centers and Teams.
Behavioral health
Cardiovascular health
Center for Evaluation and Survey Research
Critical Care Research Center
Diabetes
International Diabetes Center
Orthopedic trauma
Primary care, pediatrics
Research Methodology Group
TRIA Research and Education Center
Worksite and occupational health
Cancer Research Center
Center for Chronic Care Innovation
Community and population health
Dental and oral health
Health economics
Neuroscience Research Centers
Pregnancy and child health
Pulmonology
Rheumatology
Vaccines
Knowledge
About
About
FAQ
HealthPartners Institute
People
Centers & Teams
Knowledge
About
HealthPartners Institute
J. A. Sparano
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: patient-reported outcomes in ECOG-ACRIN EA1131
.
Cancer.
2024
Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ECOG-ACRIN EA1131
.
Journal of Clinical Oncology.
2021
Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102
.
Journal of Clinical Oncology.
2018
Contact
full name
J. A.
Sparano
Quick Info
Collaboration
Co-author network
Map of science
Picked up by
6
news outlets
Referenced in
1
policy sources
Posted by
87
X users
On
1
Facebook pages
Referenced in
1
clinical guideline sources
128
readers on Mendeley
See more details
Picked up by
6
news outlets
Referenced in
1
policy sources
Posted by
17
X users
Referenced in
1
patents
On
1
Facebook pages
215
readers on Mendeley
See more details
Posted by
25
X users
4
readers on Mendeley
See more details